United States of America – October 17, 2025 – The Insight Partners announces the release of its report, “Histopathology Services Market: Segmentation, Growth, and Leading Companies.” The report highlights market drivers, detailed segmentation, and profiles of the key organizations operating in histopathological diagnostics and research through 2028.

Overview of Histopathology Services Market

The histopathology services market is projected to reach US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021, growing at a CAGR of 5.7% from 2021 to 2028. This growth is driven by increasing demand for biologics, a rising prevalence of chronic diseases, and technological advancements in pathology imaging and biopsy techniques. These developments are helping improve diagnostic accuracy and speed, especially in cancer and autoimmune conditions.​

Get Sample PDF:- 

Segments Covered

• By Type of Examination
  • Surgical Specimen
  • Breast Biopsy
  • Lung Biopsy
  • Renal Biopsy
  • Gastrointestinal Biopsy
  • Pancreatic Biopsy
  • Skin Tissue Biopsy
  • Testicular Biopsy
• By End User
  • Diagnostic Laboratories & Reference Laboratories
  • Research Institutes
  • Others

Spotting Emerging Trends

• Technological Advancements:The adoption of digital pathology, AI-assisted image analysis, and enhanced sample preservation methods are boosting diagnostic precision and workflow efficiency.​
• Changing Clinical Practices:Increasing awareness of early disease detection and rising preference for minimally invasive biopsy approaches are improving patient outcomes and enabling broader use in outpatient settings.​
• Regulatory Developments:Greater emphasis on quality assurance, collaboration across biomedical research, and regulatory alignment for biomarker testing are supporting innovation while maintaining clinical reliability.​

Growth Opportunities

The global expansion of precision medicine and clinical trials requiring detailed tissue analysis is reinforcing demand for high-quality histopathology support services. Growth prospects are especially strong in Asia-Pacific and North America, driven by healthcare modernization and the increasing number of biologics entering production pipelines.​

Market Leaders and Key Company Profiles

• Sonic Healthcare Limited
• Laboratory Corporation of America Holdings
• Acculabs Diagnostics UK Ltd
• TPL Path Labs
• UNILABS
• Cureline Global Translational CRO
• Targos
• Cellular Pathology Services
• Experimental Pathology Laboratories Inc (EPL)

Conclusion

The Histopathology Services Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021–2028 provides a strategic overview of the evolving histopathology landscape. With growing adoption of advanced diagnostic technologies and precision-based workflows, key players continue to expand their footprint across clinical diagnostics and research applications. This market remains central to modern medicine’s ability to identify, map, and monitor disease progress effectively.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch